acorda therapeutics Pages on BioPortfolio:

BioPortfolio - chondroitinase acorda therapeutics price
23, 2005--Results of a preclinical study from Acorda Therapeutics showed chondroitinase ... Acorda Therapeutics to Present an Overview of its Preclinical
. ...
http://www.bioportfolio.com/search/chondroitinase_acorda_the...

Biotechnology News Sepracor wessel. acorda. lunesta. planck. eu ...
Acorda Therapeutics to Present at the Piper Jaffray 20th Annual Healthcare Conference HAWTHORNE, N.Y.-(Business Wire)-November 25, 2008 - Acorda ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Biotechnology News Sepracor Search
Acorda Therapeutics Names Thomas C. Wessel, M.D., Ph.D., as Chief Medical .... Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Thomas C. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Acorda Therapeutics - Profile
View the current Acorda Therapeutics Page on BioPortfolio.com ... Acorda Therapeutics, Inc. was established in March 1995 to develop therapeutic products
...
http://www.bioportfolio.com/biocorporate/91-Acorda+Therapeut...

Biotechnology News Sepracor wessel. acorda. acor. planck. lunesta ...
Matching: sepracor wessel acorda planck, Find similar documents. HTML. 31%. Acorda Therapeutics to Present at the Lazard Capital Markets 5th Annual ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Biotechnology News Paraparesis Tropical Spastic Search
Acorda Therapeutics to Present at the Lazard Capital Markets 5th Annual Healthcare Conference HAWTHORNE, N.Y.-(Business Wire)-November 13, 2008 - Acorda
...
http://www.bioportfolio.co.uk/Paraparesis%20Tropical%20Spast...

BioPortfolio - Acorda Therapeutics
Acorda Therapeutics - BioPortfolio. ... Acorda Therapeutics - Entry on Bioportfolio's Biocorporate Database. ...
http://www.bioportfolio.com/search/Acorda_Therapeutics.html...

Biotechnology and Pharmaceutical Industry Search Find Companies ...
Acorda Therapeutics to Present at the Piper Jaffray 20th Annual Healthcare ... Acorda Therapeutics, Inc. - Acorda Therapeutics Reports Third Quarter 2008 ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Results from other life science and pharmaceutical sites:

BioSpace - Acorda Therapeutics News, Search Jobs, Events
Acorda Therapeutics (ACOR) Presents Additional Data from Second Positive Phase 3 Study of Fampridine-SR at World Congress on Treatment and Research in ...
http://www.biospace.com/company_profile.aspx?CompanyId=10070...

...

Acorda Therapeutics Names Thomas C. Wessel, M.D., Ph.D., as Chief ...
HAWTHORNE, NY--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR - News) ... Acorda Therapeutics is a biotechnology company developing therapies for ...
http://biz.yahoo.com/bw/081112/20081112005343.html?.v=1...

News: Acorda Therapeutics Names Thomas C. Wessel, M.D., Ph.D., as ...
12 Nov 2008 ... Acorda Therapeutics Names Thomas C. Wessel, MD, Ph.D., as Chief Medical Officer. Genetic Engineering & Biotechnology News - Biotechnology ...
http://www.genengnews.com/news/bnitem.aspx?name=45345994...

Fampridine Acorda Therapeutics Cynthia Darlington
Elan and Acorda Therapeutics were evaluating fampridine for treatment of spinal cord injuries .... 350955 Drug development pipeline - Acorda Therapeutics. ...
http://www.biomedcentral.com/content/pdf/cd-444349.pdf...

...

Acorda Therapeutics and FDA Reach Agreement on Special Protocol ...
These statements are subject to risks and uncertainties that could cause actual results to differ materially, including Acorda Therapeutics' ability to ...
http://www.biospace.com/news_story.aspx?NewsEntityId=57278...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.